News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Kala Pharmaceuticals, Inc.
Kala Pharmaceuticals Announces Name Change to KALA BIO
August 02, 2023
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
KALA
Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 19, 2023
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
KALA
Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 23, 2023
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
KALA
Kala Pharmaceuticals to Present at the Jefferies Healthcare Conference
June 02, 2023
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
KALA
Kala Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 09, 2023
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
KALA
Combangio, Inc., a Wholly Owned Subsidiary of Kala Pharmaceuticals, Awarded $15 Million by California Institute for Regenerative Medicine to Support Ongoing KPI-012 Program for the Treatment of PCED
April 28, 2023
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
KALA
Kala Pharmaceuticals Receives FDA Fast Track Designation for KPI-012, a Human MSC-S Therapy for Persistent Corneal Epithelial Defect
April 12, 2023
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
KALA
Kala Pharmaceuticals Appoints Dr. Francis Mah as Chief Medical Advisor
March 29, 2023
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
KALA
Kala Pharmaceuticals Announces Positive Safety Update from Cohort 1 of CHASE Phase 2b Clinical Trial Evaluating KPI-012 in Patients with PCED
March 27, 2023
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
KALA
Kala Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 08, 2023
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
KALA
Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
March 03, 2023
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
KALA
Kala Pharmaceuticals Announces FDA Acceptance of IND Application for KPI-012 for the Treatment of PCED
December 27, 2022
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
KALA
Kala Pharmaceuticals Announces Submission of Investigational New Drug Application for KPI-012 for the Treatment of Persistent Corneal Epithelial Defect
November 28, 2022
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
KALA
Kala Pharmaceuticals Announces Up to $31 Million Private Placement Financing
November 28, 2022
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
KALA
Kala Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 08, 2022
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
KALA
Kala Pharmaceuticals Announces Appointment of Marjan Farid, M.D., to its Board of Directors
November 01, 2022
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
KALA
Kala Pharmaceuticals Announces Reverse Stock Split
October 20, 2022
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
KALA
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
June 18, 2021
From
Kala Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALA
Kala Pharmaceuticals Announces EYSUVIS® Now Covered by OptumRx
June 03, 2021
From
Kala Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALA
Kala Pharmaceuticals to Present at Jefferies 2021 Virtual Healthcare Conference
May 27, 2021
From
Kala Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALA
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
May 20, 2021
From
Kala Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALA
Kala Pharmaceuticals to Present at BofA Securities 2021 Healthcare Conference
May 06, 2021
From
Kala Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALA
Kala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 05, 2021
From
Kala Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALA
Kala Pharmaceuticals to Report First Quarter 2021 Financial Results and Host Conference Call
April 28, 2021
From
Kala Pharmaceuticals, Inc.
Via
Business Wire
Tickers
KALA
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.